Skip to content
2000
Volume 23, Issue 1
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873

Abstract

Sleep plays an important function in neuro-immuno-endocrine homeostasis. Sleep disorders have been associated with an increased risk of metabolic and cognitive impairments. Among different factors that have an effect on sleep metabolism, a growing body of literature has investigated growth factors in the course of sleep quality and disorders. A good example of growth factors is fibroblast growth factors (FGFs), which are a large family of polypeptide growth factors. Evidence has shown that FGFs are involved in the modulation of sleep-wake behavior by their receptor subtypes and ligands, e.g., FFG1 plays an important role in the quality of sleep through somnogenic effects, while the high level of FGF23 is associated with secondary disorders in shift workers. Therefore, a controversial effect of FGFs can be seen in the course of sleep in physiologic and pathologic conditions. Further investigation on this topic would help us to understand the role of FGFs in sleep disorders as a therapeutic option and biomarker.

Loading

Article metrics loading...

/content/journals/emiddt/10.2174/1871530322666220802161031
2023-01-01
2024-11-26
Loading full text...

Full text loading...

/content/journals/emiddt/10.2174/1871530322666220802161031
Loading

  • Article Type:
    Review Article
Keyword(s): circadian rhythm; Fibroblast growth factor; inflammation; insomnia; neurotrophic; sleep
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test